Beiersdorf Expands Epigenetic Skin Care Research With New Day Cream

Beiersdorf reports more than 17 years of epigenetics research and says its patented Skin Age Clock, built on more than 1,000 skin samples, measures biological skin age. The company says its epigenetic active ingredient EPICELLINE® has been shown to reduce biological skin age. A study of an epigenetic serum containing dihydromyricetin (DHM) found that 40 percent of test subjects showed a biological skin age reduction of up to five years. The new day cream combines the epigenetic active with SPF 30, while night and eye creams are also planned.

Key facts

Market context

Epigenetic actives are ingredients intended to influence gene expression in skin cells, and they sit within the broader anti-aging and skin longevity segment of cosmetics and personal care. Demand in this space is driven by consumers in premium skin care who increasingly expect scientific substantiation, clinical testing and measurable claims rather than general moisturizing or wrinkle-reduction promises. Dihydromyricetin is a plant-derived flavonoid-type compound that has been studied for cosmetic and nutraceutical uses, while sun protection factor ingredients are standard components of daytime facial products, so combining the two in one formula is a common routine-building approach. For chemical buyers, moves like this can support demand for specialty active ingredients and niche botanical extracts, which typically sell at higher margins than commodity cosmetic raw materials. Competitors in skin care ingredients often respond by developing their own proprietary actives or age-measurement tools, which can increase differentiation and patent activity in the category.

Source: official release on beiersdorf.com. Summary and context written by Market Krystal.